-
摘要:
目的 分析2014年福建省肿瘤登记地区恶性肿瘤发病与死亡状况，为肿瘤防治提供科学依据。 方法 根据全国肿瘤登记中心制定的数据审核和评价方法，对福建省12个肿瘤登记处上报的2014年数据进行评价，将符合要求的9个登记处数据合并分析。计算发病和死亡粗率、标化率、累积率（0~74岁），分析主要恶性肿瘤发病与死亡顺位。中国人口标化率（中标率）根据2000年中国标准人口构成计算，世界人口标化率（世标率）依照Segi's标准人口构成计算。 结果 2014年9个肿瘤登记处（城市4个，农村5个）覆盖人口5 192 590人（城市2 673 166人，农村2 519 424人）。组织学诊断比例（MV%）为73.32%，死亡/发病比（M/I）为0.69，仅有死亡医学证明书病例比例（DCO%）为0.25%。福建省恶性肿瘤发病率为254.13/10万（其中男性306.37/10万，女性200.62/10万），中标率为196.12/10万，世标率为191.96/10万，累积率（0~74岁）为22.83%。其中城市地区发病率为277.46/10万，中标率为215.86/10万；农村地区发病率为229.38/10万，中标率为175.89/10万。福建省恶性肿瘤死亡率为175.71/10万（其中男性235.47/10万，女性114.50/10万），中标率为130.13/10万，世标率为128.61/10万，累积率（0~74岁）为15.04%。其中城市地区死亡率为185.62/10万，中标率为137.88/10万；农村地区死亡率为165.20/10万，中标率为122.82/10万。肺癌、肝癌、胃癌、乳腺癌和结直肠癌居恶性肿瘤发病前5位，肺癌、肝癌、胃癌、食管癌和结直肠癌居恶性肿瘤死亡前5位。 结论 消化系统肿瘤、肺癌、乳腺癌是福建省最主要的恶性肿瘤，应作为肿瘤防治的重点，积极推广筛查工作，降低居民的肿瘤疾病负担。 Abstract:Objective To analyze the cancer incidence and mortality in Fujian in 2014 and provide a scientific basis for tumor prevention. Methods In accordance with the methods and criteria of data quality control made by National Central Cancer Registry (NCCR), data from 9 registries were distinguished from those of 12 submitted registries in Fujian after assessment, merging and analysis of the data. The crude rate, standard rate, cumulative rates (0-74 years old) and proportion of leading cancers were calculated. The China 2000 Population Census data and Segi's standard population were used for calculating age-standardized rates. Results The population from 9 cancer registries (4 in urban and 5 in rural areas) was 5, 192, 590 (2, 673, 166 in urban and 2, 519, 424 in rural areas). The morphology-verified cases accounted for 73.32%; 0.25% of incident cases were identified through death certifications only, and the mortality to incidence ratio was 0.69. In 2014, the cancer incidence rate was 254.13/105 (306.37/105 in men and 200.62/105 in women). The agestandardized incidence by the Chinese standard population (ASIRC) and by the world standard population were 196.12/105 and 191.96/ 105, respectively, while the cumulative incidence (0-74 years old) was 22.83%. The cancer incidence and ASIRC were 277.46/105 and 215.86/105 in urban areas, respectively, whereas in rural areas, they were 229.38/105 and 175.89/105, respectively. The cancer mortality was 175.71/105 (235.47/105 in men and 114.50/105 in women). The age-standardized mortality by the Chinese standard population (ASMRC) and by the world standard population were 130.13/105 and 128.61/105, respectively, and the cumulative mortality rate (0-74 years old) was 15.04%. The cancer mortality and ASMRC were 185.62/105 and 137.88/105 in urban areas, respectively, whereas in rural areas, they were 165.20/105 and 122.82/105, respectively. Lung cancer had the highest incidence followed by liver, gastric, breast, and colorectal cancer. Moreover, lung cancer had the higher mortality rate followed by liver, gastric, esophageal, and colorectal cancer. Conclusions Digestive system neoplasms, lung cancer, and breast cancer were the most common cancers in Fujian. Active screening should be the focus of cancer prevention to reduce the burden of cancer. -
Key words:
- cancer registry /
- incidence /
- mortality /
- Fujian province /
- tumor screening
-
表 1 2014年福建省肿瘤登记地区恶性肿瘤发病主要指标
表 2 2014年福建省肿瘤登记地区全部恶性肿瘤死亡主要指标
表 3 2014年福建省肿瘤登记地区发病率前10位恶性肿瘤
表 4 2014年福建省肿瘤登记地区死亡率前10位恶性肿瘤
-
[1] 黄少芬, 李晓庆, 林修全, 等.1990和2013年福建省恶性肿瘤疾病负担分析[J].中国慢性病预防与控制, 2018, 26(3):198-202. http://d.old.wanfangdata.com.cn/Periodical/zgmxbyfykz201803009 [2] 国家癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社, 2016:59-75. [3] Bray F, Parkin DM. Evaluation of data quality in the cancer registry : principles and methods. Part Ⅰ:comparability, validity and timeliness[J]. Eur J Cancer, 2009, 45(45):747-755. [4] Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods. Part Ⅱ: completeness[J]. Eur J Cancer, 2009, 45(45):756-764. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_80648f7b380f183024687648a8059b44 [5] 陈万青, 孙可欣, 郑荣寿, 等.2014年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤, 2018, 27(1):1-14. http://d.old.wanfangdata.com.cn/Periodical/zgzl201801001 [6] 鲍萍萍, 龚杨明, 彭鹏, 等.2014年上海市恶性肿瘤发病和死亡特征分析[J].中国癌症杂志, 2018, 28(3):161-176. http://d.old.wanfangdata.com.cn/Periodical/zgazzz201803001 [7] 朱陈, 杜灵珊, 李辉章, 等.2014年浙江省肿瘤登记地区恶性肿瘤发病与死亡分析[J].中国肿瘤, 2018, 27(1):15-22. http://d.old.wanfangdata.com.cn/Periodical/zgzl201801002 [8] 韩仁强, 武鸣, 罗鹏飞, 等.2014年江苏省恶性肿瘤发病和死亡分析[J].肿瘤预防与治疗, 2018, 31, (1):24-31. doi: 10.3969/j.issn.1674-0904.2018.01.005 [9] 许可葵, 王静, 廖先珍, 等.2014年湖南省肿瘤登记地区恶性肿瘤的发病和死亡分析[J].中国肿瘤, 2018, 27(2):86-95. http://d.old.wanfangdata.com.cn/Periodical/zgzl201802003 [10] 马晶昱, 肖景榕, 周衍, 等.2013年福建省肿瘤登记地区恶性肿瘤发病与死亡分析[J].中国肿瘤, 2018, 27(3):167-173. http://d.old.wanfangdata.com.cn/Periodical/zgzl201803002 [11] Ferroa A, Peleteiro B, Malvezzi M, et al. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype[J]. J Cancer, 2014, (50):1330-1344. [12] 左婷婷, 郑荣寿, 曾红梅, 等.中国胃癌流行病学现状[J].中国肿瘤临床, 2017, 44(1):52-58. doi: 10.3969/j.issn.1000-8179.2017.01.881 [13] 左婷婷, 郑荣寿, 曾红梅, 等.中国食管癌发病状况与趋势分析[J].中华肿瘤杂志, 2016, 38(9):703-708. doi: 10.3760/cma.j.issn.0253-3766.2016.09.013 [14] Zeng H, Zheng R, Guo Y, et al. Cancer survival in China: 2003-2005 a population based study[J]. Int J Cancer, 2015, 136(8):1921-1930. http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_2375426 [15] Leong K, Hartley J, Karandikar S. Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus(2017)-follow up, lifestyle and survivorship[J]. Colorectal Dis, 2017, 19(S1):67-70. http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_1356377 [16] Yusof AS, Isa ZM, Shah SA. Dietary patterns and risk of colorectal cancer: a systematic review of cohort studies (2000-2011)[J]. Asian Pac J Cancer Prev, 2012, 13(9):4713-4717. doi: 10.7314/APJCP.2012.13.9.4713 [17] Yao C, Nsah G F, Hickish T. Management of colorectal cancer and diabetes[J]. J R Soc Med, 2014, 107(3): 103-109. doi: 10.1177/0141076813512121 [18] 李道娟, 李倩, 贺宇彤.结直肠癌流行病学趋势[J].肿瘤防治研究, 2015, 42(3):305-310. doi: 10.3971/j.issn.1000-8578.2015.03.020 [19] 郑莹, 龚杨明, 顾凯, 等.上海市社区居民大肠癌筛查项目[J].上海预防医学, 2016, 28(10):739-742. http://d.old.wanfangdata.com.cn/Conference/8740206 [20] IARC. Lung Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.2012. [21] 邹小农, 贾漫漫, 王鑫, 等.中国肺癌和烟草流行及控烟现状[J].中国肺癌杂志志, 2017, 20(8):505-510. http://d.old.wanfangdata.com.cn/Periodical/zgfazz201708001 [22] MOYER V. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement[J]. AnnIntern Med, 2014, 160(5):330. [23] 师金, 梁迪, 李道娟, 等.全球女性乳腺癌流行情况研究[J].中国肿瘤, 2017, 26(9):683-690. http://d.old.wanfangdata.com.cn/Periodical/zgzl201709006 -
下载:
点击查看大图
图(1) / 表(4)
计量
- 文章访问数: 70
- HTML全文浏览量: 4
- PDF下载量: 4
- 被引次数: 0
